openPR Logo
Press release

Global Crohn's Disease Market is Driven by Increasing Incidence of Bowel Disorders

07-24-2017 02:12 PM CET | Health & Medicine

Press release from: Transparency Market Research

Global Crohn's Disease Market is Driven by Increasing Incidence

Crohn's disease is a prolonged inflammatory disease of the bowel, affecting any part of the gastrointestinal tract, i.e. from the mouth to the anus. Crohn's disease is frequently diagnosed in two different age groups, first between 15 and 35 years old and second between 60 and 80 years old. The disease is mainly characterized by abdominal pain, diarrhea (with or without blood), fever, and weight loss.

Additionally, extraintestinal conditions such as arthritis, erythema nodosum, and uveitis are detected among half of the patients. Prevalence and incidence of Crohn's disease is rising globally since the last few years. The exact cause of Crohn's disease is not recognized; however, some factors such as genetic malfunctions concerning the immune system concurrent with some environmental factors such as normal flora of human gut, smoke, foods, chemical contamination, or pollution triggers the occurrence of Crohn’s disease in susceptible people.

Obtain Report Details @ http://www.transparencymarketresearch.com/crohns-disease-market.html

The global Crohn’s disease market is driven by increasing incidence of bowel disorders such as Crohn’s disease, leading to drug innovations for treatment. Crohn’s disease is more prevalent in developed and industrialized countries, particularly in individuals who smoke, and also with changing food habits, such as preference of fast food over vegetables and fruits. Therefore, rising patient population due to lifestyle changes and other factors also contributes to the expansion of the market.

Furthermore, rising demand for biologics for treatment of bowel disorders such as Crohn’s disease, increasing awareness about Crohn’s disease, and the available treatments are estimated to propel the global market. Additionally, drug manufacturers are vigorously focusing on innovative products having more efficiency. Therefore, increased preference and utilization for anti-inflammatory drugs and biologics coupled with the rising acceptance of biosimilars is anticipated to play a significant role in boosting the Crohn’s disease market during the forecast period.

Therefore, the Crohn’s disease market is projected to witness key trends such as increased preference for symptomatic drugs and therapeutic over surgeries, better disease management for inflammatory bowel diseases like Crohn’s disease, and the arrival of improved drugs in the market due to better investments in R&D programs, prevailing the market. However, high cost of treatment is likely to be a major restraint for the market. Moreover, lack of early diagnosis, mostly in developing countries, and the patent expiry of blockbuster drugs may hamper the expansion of the market in the near future.

The global Crohn’s disease market can be segmented into diagnosis, drug type, and region. Crohn’s disease can be diagnosed by blood test, colonoscopy, capsule endoscopy, sigmoidoscopy, small bowel imaging, double-balloon endoscopy, computerized tomography (CT), and magnetic resonance imaging (MRI). In terms of drug type, the market can be segmented into anti-diarrheal, antiinflammatory drugs, immuno suppressors, antibiotics, and pain relievers.

In terms of geography, the Crohn’s disease market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America dominates the global Crohn’s disease market. Major share of the region is attributed to the significant incidence of Crohn’s disease in the region, mainly Canada and the US (Ranjbar et. al. 2015), unhealthy life style including fast food consumption and smoking habits, progressive healthcare infrastructure and innovative healthcare solutions. Europe follows North America in terms of share of the global Crohn’s disease market.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26834

The Crohn’s disease market in Asia Pacific is projected to expand at a high growth rate. This rise is primarily due to changing food habits, industrialization, and innovative diagnostic and treatment options for the disease. Major players in the market find countries in Asia to be productive markets for Crohn’s disease with the increasing incidence of the disease in the countries in the region. They are making significant investments, which in turn is likely to fuel the expansion of the market in the region.

Key players operating in the global Crohn’s disease market include AbbVie Inc., Allergan, Inc., Bayer AG, Bristol-Myers Squibb, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche, Eli Lilly and Co., GlaxoSmithKline plc, Janssen Biotech, Inc., Johnson & Johnson, Novartis International AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Company Limited.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Crohn's Disease Market is Driven by Increasing Incidence of Bowel Disorders here

News-ID: 638436 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for Crohn

Global Companion Animal Specialty Drugs and Crohn s Disease Drug (COVID-19 Imapa …
The Companion Animal Specialty Drugs Market ( https://bit.ly/31KDIZZ ) report is intended to function as a supportive means to assess the Companion Animal Specialty Drugs market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the
Crohns Disease Drug Market 2020 Recent Industry Developments and Growth Strateg …
ReportsnReports provides in depth study of "Crohns Disease Drug Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organisation. The Crohns Disease Drug Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organisation such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organisation. The global
Crohns Disease Drugs Market Research and Clinical Analysis 2020 - Bayer AG, Amg …
The Crohn's Disease Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Order a Copy of
Crohn s Disease Drug Market to Witness Huge Growth by 2025 | AbbVie, Janssen Bio …
HTF MI recently introduced Global Crohn s Disease Drug Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AbbVie, Janssen Biotech, UCB, Amgen, Tillotts Pharma & Takeda
Crohn Disease Market 2018 by its Scientific Reviews, Clinical Application and Ke …
Global Crohn Disease Market Professional Survey Report 2018 to 2025 presents an in-depth assessment of the Crohn Disease Market including enabling key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Crohn Disease Market investments from 2018 till 2025. This study answers several questions for stakeholders, primarily which market segments
Crohn Disease Market Set for Expansive Growth by 2022
This report studies the global Crohn Disease market, analyzes and researches the Crohn Disease development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Johnson & Johnson Pfizer Sanofi Merck GSK AbbVie Takeda Ferring UCB Boehringer Ingelheim Ask for sample copy @ http://www.researchtrades.com/request-sample/1117798 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Crohn Disease can be split into Small Intestine and Ileocephalitis Colon Disease Market segment